Edition:
United Kingdom

Zogenix Inc (ZGNX.OQ)

ZGNX.OQ on NASDAQ Stock Exchange Global Market

47.35USD
7:41pm BST
Change (% chg)

$-0.60 (-1.25%)
Prev Close
$47.95
Open
$47.65
Day's High
$48.25
Day's Low
$47.00
Volume
110,421
Avg. Vol
140,642
52-wk High
$48.25
52-wk Low
$10.05

Latest Key Developments (Source: Significant Developments)

Zogenix Says Repaid Entire $20.1 Mln Of Outstanding Principal & Interest Under Its Loan And Security Agreement
Friday, 29 Dec 2017 

Dec 29 (Reuters) - Zogenix Inc ::ZOGENIX SAYS REPAID IN FULL ENTIRE $20.1 MILLION OF OUTSTANDING PRINCIPAL & INTEREST UNDER ITS LOAN AND SECURITY AGREEMENT DATED AS OF DEC 30, 2014.ZOGENIX SAYS IN CONNECTION WITH REPAYMENT, CO WAS ALSO REQUIRED TO MAKE FINAL PAYMENT OF ABOUT $1.4 MILLION, OTHER PAYMENTS - SEC FILING.  Full Article

Zogenix Announces New Data From Pivotal Phase 3 Clinical Trial Of ZX008
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Zogenix Inc ::ZOGENIX ANNOUNCES NEW POSITIVE EFFICACY AND SAFETY DATA FROM PIVOTAL PHASE 3 CLINICAL TRIAL OF ZX008 IN DRAVET SYNDROME.ZOGENIX INC - DATA SHOWS ZX008 PATIENTS MORE LIKELY TO ACHIEVE CLINICALLY MEANINGFUL REDUCTION IN SEIZURE FREQUENCY COMPARED TO THOSE ON PLACEBO.ZOGENIX INC - LOOK FORWARD TO SHARING TOP-LINE RESULTS FROM SECOND PIVOTAL PHASE 3 TRIAL OF ZX008, STUDY 1504, IN Q2 OF 2018.  Full Article

Zogenix Announces Initiation Of Phase 3 Trial For ZX008 In Lennox-Gastaut Syndrome
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Zogenix Inc ::ZOGENIX ANNOUNCES INITIATION OF PHASE 3 TRIAL FOR ZX008 IN LENNOX-GASTAUT SYNDROME.  Full Article

Zogenix posts Q3 loss of $1.68 per share
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Zogenix Inc :Zogenix provides corporate update and reports third quarter 2017 financial results.Q3 earnings per share view $-0.93 -- Thomson Reuters I/B/E/S.Q3 loss per share $1.68.At September 30, 2017, company had cash and cash equivalents of $64.7 million, compared to $91.6 million at December 31, 2016​.  Full Article

Zogenix amends manufacturing services agreement
Friday, 26 Aug 2016 

Zogenix Inc [ZGNX.O] : Zogenix Inc Co, Patheon UK limited entered into amendment to the manufacturing services agreement, dated February 28, 2013 .The expiration of the term of the services agreement has been retroactively extended from July 31, 2016 to October 31, 2016 - SEC filing.  Full Article

Zogenix Q2 loss per share $0.76
Tuesday, 9 Aug 2016 

Zogenix Inc : Zogenix provides corporate update and reports second quarter 2016 financial results . Q2 earnings per share view $-0.81 -- Thomson Reuters I/B/E/S . Q2 revenue view $5.4 million -- Thomson Reuters I/B/E/S . Q2 loss per share $0.76 . Q2 revenue $2.1 million .Zogenix inc says zogenix is reiterating its previously provided financial guidance for full year 2016.  Full Article

BRIEF-Zogenix Q1 Loss Per Share $0.87

* ZOGENIX PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER FINANCIAL RESULTS